BMS-983970 is primarily utilized in the field of medical research, particularly in the study of cancer therapies. It functions as a potent inhibitor targeting specific enzymes or proteins involved in tumor growth and proliferation. Researchers employ this compound to investigate its efficacy in halting the progression of various cancers, including solid tumors and hematologic malignancies. Its application extends to preclinical studies where it is tested in vitro and in vivo to understand its mechanism of action, pharmacokinetics, and potential therapeutic benefits. Additionally, BMS-983970 is used in combination studies with other anticancer agents to evaluate synergistic effects and improve treatment outcomes. This compound plays a crucial role in advancing the development of targeted cancer therapies and enhancing precision medicine approaches.